Evidence map›Paper›PMID 30271766›Full record

ArticleCanadian journal of gastroenterology & hepatology2018

The Relationship between Gender, Severity of Disease, Treatment Type, and Employment Outcome in Patients with Inflammatory Bowel Disease in Israel.

Timna Naftali, Adi Eindor-Abarbanel, Nahum Ruhimovich, Ariella Bar-Gil Shitrit, Fabiana Sklerovsky-Benjaminov, Fred Konikoff, Shay Matalon, Haim Shirin, Yael Milgrom, Tomer Ziv-Baran and 1 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Canadian journal of gastroenterology & hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Feeding Difficulties Associated with IBD during the Working Day: Qualitative Study, Alicante Spain.International journal of environmental research and public health · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Timna NaftaliDepartment of Gastroenterology and Hepatology, Meir Medical Center, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Adi Eindor-AbarbanelThe Kamila Gonczarowski Institute for Gastroenterology and Liver Diseases, Assaf Harofeh Medical Center, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0001-9677-0453
Nahum RuhimovichDepartment of Gastroenterology and Hepatology, Meir Medical Center, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ariella Bar-Gil ShitritDigestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Fabiana Sklerovsky-BenjaminovDepartment of Gastroenterology and Hepatology, Meir Medical Center, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Fred KonikoffDepartment of Gastroenterology and Hepatology, Meir Medical Center, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Shay MatalonThe Kamila Gonczarowski Institute for Gastroenterology and Liver Diseases, Assaf Harofeh Medical Center, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0003-1608-5195
Haim ShirinThe Kamila Gonczarowski Institute for Gastroenterology and Liver Diseases, Assaf Harofeh Medical Center, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0002-3375-4963
Yael MilgromDigestive Diseases Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Tomer Ziv-BaranDepartment of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Efrat BroideThe Kamila Gonczarowski Institute for Gastroenterology and Liver Diseases, Assaf Harofeh Medical Center, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0003-0427-8491
Tel Aviv University · ILShaare Zedek Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Since individuals with IBD typically experience symptoms during their prime years of employment, it raises the question about IBD impact on employment status. Most studies concentrated on absenteeism from work with varying results in different populations. However, absenteeism reflects only one dimension of the ability to work and does not expose the problem of inability to hold a full-time job. Aims: To evaluate the influence of IBD on unemployment and working hours in Israel. Secondary aims were to investigate the correlation between working hours and the type of medical treatment and the impact of severity of disease. Patients and Methods: Demographic data, employment status, number of weekly working hours, and disease parameters. The data was compared to that of the general Israeli population extracted from the website of the Central Bureau of Statistics. Results: 242 IBD patients were interviewed. Patients median age was 37.04(IQR 30.23-44.68) years and 88 (36.4%) were men and 154 (63.6%) women. Diagnosis of CD was established in 167 (69%) patients and UC in 65 (26.9%). There was no significant reduction in employment rates or working hours among the IBD patients comparing to the general population. Immunosuppressive or biologic treatment did not influence employment status. The unemployed patients had higher disease severity (median 7.33, IQR 5-10.66) compared to employed patients (median 6, IQR 3.66-7.66; p=0.003). Conclusions: Although IBD patients in Israel do not have higher unemployment, those with severe disease have lower proportion of employment.

Indexed as

AbsenteeismAdultAgedAge FactorsCohort StudiesEmploymentFemaleHumansInflammatory Bowel DiseasesIsraelMaleMiddle AgedRetrospective StudiesRisk AssessmentSeverity of Illness IndexSex Factors

Identifiers

PMID30271766
PMCPMC6151233
OpenAlexW2890532318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.